Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Guided Therapeutics's operating income for the twelve months ending Jun 30, 2026 was -$1.98M. For fiscal 2025 it was -$2.37M. The highest annual figure on record is -$937.00K in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.37M | – |
| FY2024 | Dec 31, 2024 | -$2.11M | – |
| FY2023 | Dec 31, 2023 | -$3.46M | – |
| FY2022 | Dec 31, 2022 | -$3.33M | – |
| FY2021 | Dec 31, 2021 | -$2.36M | – |
| FY2020 | Dec 31, 2020 | -$1.05M | – |
| FY2019 | Dec 31, 2019 | -$937.00K | – |
| FY2018 | Dec 31, 2018 | -$1.55M | – |
| FY2017 | Dec 31, 2017 | -$3.12M | – |
| FY2016 | Dec 31, 2016 | -$3.82M | – |
| FY2015 | Dec 31, 2015 | -$6.23M | – |
| FY2014 | Dec 31, 2014 | -$8.67M | – |
| FY2013 | Dec 31, 2013 | -$6.61M | – |
| FY2012 | Dec 31, 2012 | -$4.28M | – |
| FY2011 | Dec 31, 2011 | -$6.76M | – |
| FY2010 | Dec 31, 2010 | -$1.62M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$478.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$302.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$710.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$485.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$763.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$414.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$534.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$561.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$655.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$359.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$485.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$623.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.51M | – |
| Q1 FY2023 | Mar 31, 2023 | -$843.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$948.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.22M | – |
| Q2 FY2022 | Jun 30, 2022 | -$717.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$443.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$435.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$487.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$561.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$823.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$288.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$153.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$369.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$242.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$165.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$188.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$327.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$257.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$449.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$234.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$491.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$376.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$731.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.34M | – |
| Q2 FY2017 | Jun 30, 2017 | -$533.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$514.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.11M | – |
| Q3 FY2016 | Sep 30, 2016 | -$679.00K | – |
See a number that looks wrong?